NEURODERM LTD's ticker is and the CUSIP is M74231107. A total of 50 filers reported holding NEURODERM LTD in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $1,009,000 | +41.9% | 25,936 | +9.1% | 0.01% | +40.0% |
| Q2 2017 | $711,000 | +21.1% | 23,771 | +4.9% | 0.01% | +25.0% |
| Q1 2017 | $587,000 | +27.3% | 22,657 | +9.1% | 0.00% | +33.3% |
| Q4 2016 | $461,000 | -9.6% | 20,766 | -24.8% | 0.00% | -25.0% |
| Q3 2016 | $510,000 | +3.2% | 27,598 | -9.3% | 0.00% | 0.0% |
| Q2 2016 | $494,000 | +44.4% | 30,412 | +25.6% | 0.00% | 0.0% |
| Q1 2016 | $342,000 | -29.3% | 24,220 | -14.6% | 0.00% | -20.0% |
| Q4 2015 | $484,000 | -93.0% | 28,372 | -15.8% | 0.01% | -28.6% |
| Q3 2015 | $6,963,000 | +2588.4% | 33,687 | +99.7% | 0.01% | +250.0% |
| Q2 2015 | $259,000 | – | 16,873 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 327,240 | $9,784,000 | 4.26% |
| SCOPIA CAPITAL MANAGEMENT LP | 4,383,358 | $131,062,000 | 2.70% |
| SENZAR ASSET MANAGEMENT, LLC | 357,400 | $10,686,000 | 2.63% |
| Rhenman & Partners Asset Management AB | 461,654 | $13,803,000 | 1.98% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 168,025 | $5,007,000 | 1.90% |
| GREAT POINT PARTNERS LLC | 311,000 | $9,299,000 | 1.67% |
| Opaleye Management Inc. | 120,300 | $3,597,000 | 1.50% |
| SECTORAL ASSET MANAGEMENT INC | 350,085 | $10,468,000 | 1.14% |
| MENORA MIVTACHIM HOLDINGS LTD. | 808,073 | $24,161,000 | 1.13% |
| Redmile Group, LLC | 555,096 | $16,597,000 | 1.01% |